Usefulness of the aldosterone synthase gene polymorphism C-344-to predict cardiac remodeling in African-Americans versus non-African-Americans with chronic systolic heart failure

被引:11
作者
Biolo, Andreia
Chao, Tania
Duhaney, Toni-Ann S.
Kotlyar, Eugene
Allensworth-Davies, Donald
Loscalzo, Joseph
Sam, Flora [1 ]
机构
[1] Boston Univ, Sch Publ Hlth, Cardiovasc Sect, Boston, MA 02215 USA
[2] Boston Univ, Sch Publ Hlth, Evans Dept Med, Boston, MA 02215 USA
[3] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA 02215 USA
[4] Brigham & Womens Hosp, Dept Med, Boston, MA USA
关键词
D O I
10.1016/j.amjcard.2007.02.097
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A common polymorphism exists for the aldosterone synthase (CYP11B2) gene at position 344 (C-344-T). The 344-C allele has been associated with increased aldosterone synthase activity. We hypothesized that the aldosterone synthase gene polymorphism is associated with adverse cardiac remodeling in an ambulatory, chronic heart failure population. The CYP11B2 C-344T genotype was determined in 104 patients with heart failure who were in New York Heart Association classes I to IV, had left ventricular ejection fractions < 40%, and were prospectively recruited from an urban heart failure clinic (65% Aftican-American, 69% had a nonischemic cause, with a mean left ventricular ejection fraction of 22 9%). The 344-C allele frequency was 0.34 (45.2% TT, 42.3% CT, and 12.5% CC) and was significantly lower in African-American (0.27) versus Non-African-American patients (0.44, p = 0.018). Baseline and 1-year follow-up echocardiograms were obtained in 74 patients. Improvement was defined as a decrease in left ventricular end-systolic diameter (LVESD). At follow-up, the 344-C allele was associated with improved LVESD (p = 0.013). In addition, analysis by race showed that this effect was observed only in African-American patients (p < 0.006). In multivariate logistic regression, controlling for cause, gender, and spironolactone use, the TT genotype (i.e., absence of 344-C allele) was associated with a fivefold lower rate of improvement in LVESD in African-Americans (p = 0.014). In conclusion, the 344-C allele of the aldosterone synthase gene polymorphism was associated with improved cardiac remodeling over time for African-Americans with chronic systolic heart failure. Although this genetic-driven increase in aldosterone activity should predispose to worse cardiac remodeling, it may represent a more susceptible state and enhanced response to therapy in this racial subgroup. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:285 / 290
页数:6
相关论文
共 30 条
[1]   Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population [J].
Barbato, A ;
Russo, P ;
Siani, A ;
Folkerd, EJ ;
Miller, MA ;
Venezia, A ;
Grimaldi, C ;
Strazzullo, P ;
Cappuccio, FP .
JOURNAL OF HYPERTENSION, 2004, 22 (10) :1895-1901
[2]   Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2 [J].
Davies, E ;
Holloway, CD ;
Ingram, MC ;
Inglis, GC ;
Friel, EC ;
Morrison, C ;
Anderson, NH ;
Fraser, R ;
Connell, JMC .
HYPERTENSION, 1999, 33 (02) :703-707
[3]   ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR HYPERTROPHY - COMPARISON TO NECROPSY FINDINGS [J].
DEVEREUX, RB ;
ALONSO, DR ;
LUTAS, EM ;
GOTTLIEB, GJ ;
CAMPO, E ;
SACHS, I ;
REICHEK, N .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) :450-458
[4]   Racial differences in the outcome of left ventricular dysfunction [J].
Dries, DL ;
Exner, DV ;
Gersh, BJ ;
Cooper, HA ;
Carson, PE ;
Domanski, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (08) :609-616
[5]   ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) [J].
Hunt, SA ;
Baker, DW ;
Chin, MH ;
Cinquegrani, MP ;
Feldman, AM ;
Francis, GS ;
Ganiats, TG ;
Goldstein, S ;
Gregoratos, G ;
Jessup, ML ;
Noble, RJ ;
Packer, M ;
Silver, MA ;
Stevenson, LW ;
Gibbons, RJ ;
Antman, EM ;
Alpert, JS ;
Faxon, DP ;
Fuster, V ;
Gregoratos, G ;
Jacobs, AK ;
Hiratzka, LF ;
Russell, RO ;
Smith, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) :2101-2113
[6]   The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure [J].
Kotlyar, E ;
Vita, JA ;
Winter, MR ;
Awtry, EH ;
Siwik, DA ;
Keaney, JF ;
Sawyer, DB ;
Cupples, LA ;
Colucci, WS ;
Sam, F .
JOURNAL OF CARDIAC FAILURE, 2006, 12 (02) :122-127
[7]   Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension [J].
Kumar, NN ;
Benjafield, AV ;
Lin, RCY ;
Wang, WYS ;
Stowasser, M ;
Morris, BJ .
JOURNAL OF HYPERTENSION, 2003, 21 (07) :1331-1337
[8]  
Kupari M, 1998, CIRCULATION, V97, P569
[9]   Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure - Results from the A-HeFT trial [J].
McNamara, Dennis M. ;
Tam, S. William ;
Sabolinski, Michael L. ;
Tobelmann, Page ;
Janosko, Karen ;
Taylor, Anne L. ;
Cohn, Jay N. ;
Feldman, Arthur M. ;
Worcel, Manuel .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (06) :1277-1282
[10]   Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population [J].
Paillard, F ;
Chansel, D ;
Brand, E ;
Benetos, A ;
Thomas, F ;
Czekalski, S ;
Ardaillou, R ;
Soubrier, F .
HYPERTENSION, 1999, 34 (03) :423-429